article

1. Preparing to Meet the Needs of a Growing Older Adult Population with Type 1 Diabetes: A Narrative Review..  Journal of general internal medicine.  2025
2. Challenges and Opportunities for Improving Care for Type 1 Diabetes in Older Adulthood..  Diabetes care.  2025
3. Perceptions of Menopause Care: A Pilot Survey Study of Providers from Primary Care, Endocrinology, and Obstetrics and Gynecology..  Journal of women's health (2002).  34:1462-1471. 2025
4. The forgotten - overcoming challenges in diabetes care for marginalized populations..  Expert review of endocrinology & metabolism.  20:385-401. 2025
5. Perceptions of a comprehensive telehealth intervention in patients with persistently poor type 2 diabetes control..  Journal of clinical and translational science.  9:-. 2025
6. An Evidence Map of the Women Veterans' Health Literature, 2016 to 2023: A Systematic Review..  JAMA network open.  8:-. 2025
7. Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies..  The lancet. Diabetes & endocrinology.  13:427-437. 2025
8. Effectiveness of Synchronous Postdischarge Contacts on Health Care Use and Patient Satisfaction : A Systematic Review and Meta-analysis..  Annals of internal medicine.  178:229-240. 2025
9. Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review..  Digestive diseases and sciences.  70:154-167. 2024
10. Intervening on Metabolic Dysfunction-Associated Steatotic Liver Disease in Latino/a and Black Patients with Diabetes: A Feasibility Pilot..  Diabetes therapy : research, treatment and education of diabetes and related disorders.  15:2417-2427. 2024
11. Racial Disparities in Evidence-Based Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes..  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.  30:663-669. 2024
12. Evaluating Therapeutic Inertia in Two Telehealth Interventions for Type 2 Diabetes: Secondary Analyses of a Randomized Trial..  Telemedicine journal and e-health : the official journal of the American Telemedicine Association.  30:e1790-e1797. 2024
13. Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis..  BMJ open diabetes research & care.  11. 2023
14. Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead..  Diabetes care.  46:1137-1139. 2023
15. Specialist Perspectives on Delivering High-Quality Telemedicine for Diabetes: A Mixed Methods Survey Study..  Journal of the Endocrine Society.  7:-. 2023
16. Simplifying therapy to assure glycemic control and engagement (STAGE) in poorly-controlled diabetes: A pilot study..  Journal of diabetes and its complications.  37:-. 2022
17. Telehealth for the Longitudinal Management of Chronic Conditions: Systematic Review..  Journal of medical Internet research.  24:-. 2022
18. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes..  JAMA network open.  4:-. 2021
19. Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care..  Journal of the Endocrine Society.  5:-. 2021
20. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease..  Hepatology (Baltimore, Md.).  74:1220-1233. 2021
21. Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100..  Diabetes, obesity & metabolism.  23:1983-1988. 2021
22. Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease..  Medical care.  58:968-973. 2020
23. Factors associated with non-adherence to insulin and non-insulin medications in patients with poorly controlled diabetes..  Chronic illness.  18:398-409. 2020
24. Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes..  Journal of diabetes and its complications.  34:-. 2020
25. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial..  Diabetes care.  43:e108-e110. 2020
26. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review..  Annals of internal medicine.  173:110-119. 2020
27. Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting..  Therapeutic advances in chronic disease.  -. 2020
28. Clinical associations of an updated medication effect score for measuring diabetes treatment intensity..  Chronic illness.  17:451-462. 2019
29. Hospital admissions for hyperglycemic emergencies in young adults at an inner-city hospital..  Diabetes research and clinical practice.  -. 2019
30. Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin..  Metabolism: clinical and experimental.  104-111. 2019
31. Management of Preexisting Diabetes in Pregnancy: A Review..  JAMA.  321:1811-1819. 2019
32. Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study..  PloS one.  14:-. 2019
33. Triglycerides: Emerging Targets in Diabetes Care? Review of Moderate Hypertriglyceridemia in Diabetes..  Current diabetes reports.  19:-. 2019